FOUNDATIONS BUILT ON A LONG HISTORY OF COLLABORATION

While the medical uses of Marijuana have recently become of great scientific and medical interest, it has been the focus of research for over 50 years by CannBioRex’s Co-Founder’s, Prof Raphael Mechoulam, the pioneer chemist in this field, and Prof Sir Marc Feldmann, the pioneer of innovative medications for inflammation and arthritis, the blockers of TNF.